Outpatient Treatment of Croup With Nebulized Dexamethasone
- 1 April 1996
- journal article
- clinical trial
- Published by American Medical Association (AMA) in Archives of Pediatrics & Adolescent Medicine
- Vol. 150 (4) , 349-355
- https://doi.org/10.1001/archpedi.1996.02170290015002
Abstract
Purpose: To determine if treating children who have acute, moderate croup with nebulized dexamethasone sodium phosphate in the emergency department results in clinical improvement by 4 hours and a decrease in the hospitalization rate. Design: Randomized, double-blind, placebocontrolled trial. Setting: Emergency department, children's hospital. Patients: Fifty-five children with croup who were in moderate respiratory distress after treatment with mist for 30 minutes who met inclusion and exclusion criteria. Measurements: Croup score, respiratory rate, heart rate, and oxygen saturation were assessed by one of us (D.W.J. or S.S.) before treatment and 2 and 4 hours after treatment. A staff pediatrician or senior pediatric resident, also "blind" to treatment, decided on admission to or discharge from the hospital. The differences between groups for change in croup score and hospitalization rate after treatment were analyzed. Results: Evaluation of the croup scores disclosed a significant improvement in the dexamethasone-treated group compared with the placebo group at 4 hours (P=.005, Mann-WhitneyU). However, the hospitalization rate was not statistically different at the end of treatment (33% vs 52%,P=.28) or after 24 hours (48% vs 60%,P=.56, Yates corrected χ2). Our study has 80% power to detect a two-thirds reduction in hospitalization rate. Two patients with neutropenia treated with dexamethasone had a clinical course consistent with bacterial tracheitis. Conclusions: Treatment of moderate croup with nebulized dexamethasone results in clinical improvement within 4 hours. We did not show a decrease in hospitalization rates, although our sample size was only large enough to detect a 67% reduction in the rate of hospitalization. Given the infectious complications and the absence of evidence for a sustained clinical effect, we do not recommend that patients with croup be treated with nebulized dexamethasone. (Arch Pediatr Adolesc Med. 1996;150:349-355)Keywords
This publication has 16 references indexed in Scilit:
- Nebulized Budesonide for Children with Mild-to-Moderate CroupNew England Journal of Medicine, 1994
- Treatment of croup with nebulised steroid (budesonide): a double blind, placebo controlled study.Archives of Disease in Childhood, 1993
- Placebo-controlled trial of prednisolone in children intubated for croupThe Lancet, 1992
- A prospective randomized double-blind study to evaluate the effect of dexamethasone in acute laryngotracheitisThe Journal of Pediatrics, 1989
- A Randomized Double‐Blind, Placebo‐Controlled Trial of Dexamethasone and Racemic Epinephrine in the Treatment of CroupActa Paediatrica, 1988
- Management of children hospitalized for laryngotracheobronchitisPediatric Pulmonology, 1986
- The steroid-croup controversy: An analytic review of methodologic problemsThe Journal of Pediatrics, 1980
- The treatment of croup: Continued controversy due to failure of recognition of historic, ecologic, etiologic and clinical perspectivesThe Journal of Pediatrics, 1979
- A prospective randomized study to determine the efficacy of steroids in treatment of croupThe Journal of Pediatrics, 1979
- Nebulized Racemic Epinephrine by IPPB for the Treatment of CroupAmerican Journal of Diseases of Children, 1978